Clinical Trials Directory

Trials / Completed

CompletedNCT01425671

Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

Status
Completed
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
14 Years – 62 Years
Healthy volunteers
Accepted

Summary

The principle aim of the project is to analyze brain electrical activity and genetic information that will help identify the nature and cause of the disease schizophrenia. This effort should lay the groundwork for future treatment in schizophrenic patients.

Detailed description

There are several studies and hypotheses to be tested. This project includes a cross-sectional study design measuring brain waves, clinical symptoms, cognitive and functional ability, and genetic information in schizophrenic patients and normal controls. Subjects are expected to do a brain wave recording (EEG/ERP), role-play test designed to measure functionality and cognitive ability, and clinical symptom assessments. Expected duration of subject participation will be approximately 8 hours (about 2 visits). Outcome measures includes biomarkers, clinical symptoms and function, and genetic information.

Conditions

Timeline

Start date
2010-11-30
Primary completion
2023-08-01
Completion
2024-01-01
First posted
2011-08-30
Last updated
2024-04-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01425671. Inclusion in this directory is not an endorsement.